How should we measure the impact of chronic pain? Limitations of utility measurement using the EQ-5D and SF-6D

被引：6
|
作者：
Schofield, Deborah J. [1 ,2 ]
机构：
[1] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW 1450, Australia
[2] Univ Sydney, Sch Publ Hlth, Camperdown, NSW 1450, Australia
来源：
PAIN | 2014年 / 155卷 / 10期
关键词：
PREFERENCE-BASED MEASURE; HEALTH; PATIENT;
D O I：
10.1016/j.pain.2014.07.020
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：1918 / 1919
页数：2
相关论文
共 50 条
  • [1] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Kontodimopoulos, Nick
    Argiriou, Michalis
    Theakos, Nikolaos
    Niakas, Dimitris
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (04): : 383 - 391
  • [2] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Nick Kontodimopoulos
    Michalis Argiriou
    Nikolaos Theakos
    Dimitris Niakas
    The European Journal of Health Economics, 2011, 12 : 383 - 391
  • [3] The validity of estimating EQ-5D and SF-6D utility values from the HAP
    Harrison, Mark J.
    Lunt, Mark
    Bansback, Nick
    Verstapen, Suzanne
    Watson, Kath
    Symmons, Deborah
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S204 - S204
  • [4] A Comparison of SF-6D and EQ-5D Utility Scores in a Study of Patients with Schizophrenia
    McCrone, P.
    Patel, A.
    Knapp, M.
    Schene, A.
    Koeter, M.
    Amaddeo, F.
    Ruggeri, M.
    Giessler, A.
    Puschner, B.
    Thornicroft, G.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S29 - S30
  • [5] A Comparison of SF-6D and EQ-5D Utility Scores in a Study of Patients with Schizophrenia
    McCrone, Paul
    Patel, Anita
    Knapp, Martin
    Schene, Aart
    Koeter, Maarten
    Amaddeo, Francesco
    Ruggeri, Mirella
    Giessler, Anne
    Puschner, Bernd
    Thornicroft, Graham
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 (01): : 27 - 31
  • [6] COMPARISON OF THE SF-6D AND THE EQ-5D IN PATIENTS WITH SCHIZOPHRENIA
    Millier, A.
    Perthame, E.
    Aballea, S.
    Toumi, M.
    VALUE IN HEALTH, 2011, 14 (07) : A294 - A294
  • [7] SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility
    Grieve, Richard
    Grishchenko, Marina
    Cairns, John
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2009, 10 (01): : 15 - 23
  • [8] SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility
    Richard Grieve
    Marina Grishchenko
    John Cairns
    The European Journal of Health Economics, 2009, 10 : 15 - 23
  • [9] Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
    Sang-Kyu Kim
    Seon-Ha Kim
    Min-Woo Jo
    Sang-il Lee
    Health and Quality of Life Outcomes, 13
  • [10] Comparison of EQ-5D and SF-6D utilities in Pompe disease
    Kanters, T. A.
    Redekop, W. K.
    Kruijshaar, M. E.
    van der Ploeg, A. T.
    Rutten-van Molken, M. P. M. H.
    Hakkaart, L.
    QUALITY OF LIFE RESEARCH, 2015, 24 (04) : 837 - 844
12345